143 related articles for article (PubMed ID: 36342848)
21. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.
Vassilev A; Ozer Z; Navara C; Mahajan S; Uckun FM
J Biol Chem; 1999 Jan; 274(3):1646-56. PubMed ID: 9880544
[TBL] [Abstract][Full Text] [Related]
22. Bruton's tyrosine kinase (Btk) associates with protein kinase C mu.
Johannes FJ; Hausser A; Storz P; Truckenmüller L; Link G; Kawakami T; Pfizenmaier K
FEBS Lett; 1999 Nov; 461(1-2):68-72. PubMed ID: 10561498
[TBL] [Abstract][Full Text] [Related]
23. Bruton's tyrosine kinase is a substrate of calpain in human platelets.
Mukhopadhyay S; Ramars AS; Ochs HD; Dash D
FEBS Lett; 2001 Sep; 505(1):37-41. PubMed ID: 11557038
[TBL] [Abstract][Full Text] [Related]
24. Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase.
Ma YC; Huang XY
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12197-201. PubMed ID: 9770463
[TBL] [Abstract][Full Text] [Related]
25. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk.
Ellmeier W; Jung S; Sunshine MJ; Hatam F; Xu Y; Baltimore D; Mano H; Littman DR
J Exp Med; 2000 Dec; 192(11):1611-24. PubMed ID: 11104803
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK.
Forster M; Liang XJ; Schröder M; Gerstenecker S; Chaikuad A; Knapp S; Laufer S; Gehringer M
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291717
[TBL] [Abstract][Full Text] [Related]
27. Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses.
Iyer AS; Morales JL; Huang W; Ojo F; Ning G; Wills E; Baines JD; August A
J Biol Chem; 2011 Mar; 286(11):9503-13. PubMed ID: 21212279
[TBL] [Abstract][Full Text] [Related]
28. Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.
Joseph RE; Kleino I; Wales TE; Xie Q; Fulton DB; Engen JR; Berg LJ; Andreotti AH
Sci Signal; 2013 Aug; 6(290):ra76. PubMed ID: 23982207
[TBL] [Abstract][Full Text] [Related]
29. Activation mechanism and steady state kinetics of Bruton's tyrosine kinase.
Dinh M; Grunberger D; Ho H; Tsing SY; Shaw D; Lee S; Barnett J; Hill RJ; Swinney DC; Bradshaw JM
J Biol Chem; 2007 Mar; 282(12):8768-76. PubMed ID: 17264076
[TBL] [Abstract][Full Text] [Related]
30. Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma.
Wu H; Wang W; Liu F; Weisberg EL; Tian B; Chen Y; Li B; Wang A; Wang B; Zhao Z; McMillin DW; Hu C; Li H; Wang J; Liang Y; Buhrlage SJ; Liang J; Liu J; Yang G; Brown JR; Treon SP; Mitsiades CS; Griffin JD; Liu Q; Gray NS
ACS Chem Biol; 2014 May; 9(5):1086-91. PubMed ID: 24556163
[TBL] [Abstract][Full Text] [Related]
31. Electromagnetic field-induced stimulation of Bruton's tyrosine kinase.
Kristupaitis D; Dibirdik I; Vassilev A; Mahajan S; Kurosaki T; Chu A; Tuel-Ahlgren L; Tuong D; Pond D; Luben R; Uckun FM
J Biol Chem; 1998 May; 273(20):12397-401. PubMed ID: 9575194
[TBL] [Abstract][Full Text] [Related]
32. Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets. Cross-talk between tyrosine and serine/threonine kinases.
Crosby D; Poole AW
J Biol Chem; 2002 Mar; 277(12):9958-65. PubMed ID: 11788586
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
34. Bruton's tyrosine kinase phosphorylates cAMP-responsive element-binding protein at serine 133 during neuronal differentiation in immortalized hippocampal progenitor cells.
Yang EJ; Yoon JH; Chung KC
J Biol Chem; 2004 Jan; 279(3):1827-37. PubMed ID: 14597636
[TBL] [Abstract][Full Text] [Related]
35. Nucleocytoplasmic shuttling of Bruton's tyrosine kinase.
Mohamed AJ; Vargas L; Nore BF; Backesjo CM; Christensson B; Smith CI
J Biol Chem; 2000 Dec; 275(51):40614-9. PubMed ID: 11016936
[TBL] [Abstract][Full Text] [Related]
36. Bruton's tyrosine kinase: potential target in human multiple myeloma.
Liu Y; Dong Y; Jiang QL; Zhang B; Hu AM
Leuk Lymphoma; 2014 Jan; 55(1):177-81. PubMed ID: 23581641
[TBL] [Abstract][Full Text] [Related]
37. Role of the PHTH module in protein substrate recognition by Bruton's agammaglobulinemia tyrosine kinase.
Lowry WE; Huang J; Lei M; Rawlings D; Huang XY
J Biol Chem; 2001 Nov; 276(48):45276-81. PubMed ID: 11577078
[TBL] [Abstract][Full Text] [Related]
38. Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo.
Liu J; Fitzgerald ME; Berndt MC; Jackson CW; Gartner TK
Blood; 2006 Oct; 108(8):2596-603. PubMed ID: 16788103
[TBL] [Abstract][Full Text] [Related]
39. Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation.
Kaneshiro S; Ebina K; Shi K; Yoshida K; Otsuki D; Yoshikawa H; Higuchi C
J Bone Miner Metab; 2015 Sep; 33(5):486-95. PubMed ID: 25230818
[TBL] [Abstract][Full Text] [Related]
40. Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).
Gustafsson MO; Hussain A; Mohammad DK; Mohamed AJ; Nguyen V; Metalnikov P; Colwill K; Pawson T; Smith CI; Nore BF
Mol Cell Biol; 2012 Jul; 32(13):2440-53. PubMed ID: 22527282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
